Source: OncoTarget. Unidade: ICB
Subjects: NEOPLASIAS RENAIS, NEOPLASIAS PULMONARES, ADENOCARCINOMA, AMBLYOMMA CAJENNENSE, CARRAPATOS, GLÂNDULAS SALIVARES, MEDICAMENTO, METÁSTASE NEOPLÁSICA, APOPTOSE, IMUNOLOGIA
ABNT
SOUZA, Jean Gabriel de et al. Promising pharmacological profile of a Kunitz-type inhibitor in murine renal cell carcinoma model. OncoTarget, v. 7, n. 38, p. 62255-62266, 2016Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.11555. Acesso em: 14 nov. 2024.APA
Souza, J. G. de, Morais, K. L. P., Anglés-Cano, E., Boufleur, P., Mello, E. S. de, Maria, D. A., et al. (2016). Promising pharmacological profile of a Kunitz-type inhibitor in murine renal cell carcinoma model. OncoTarget, 7( 38), 62255-62266. doi:10.18632/oncotarget.11555NLM
Souza JG de, Morais KLP, Anglés-Cano E, Boufleur P, Mello ES de, Maria DA, Origassa CST, Zampolli H de C, Câmara NOS, Berra CM, Bosch RVB, Chudzinski-Tavassi AM. Promising pharmacological profile of a Kunitz-type inhibitor in murine renal cell carcinoma model [Internet]. OncoTarget. 2016 ; 7( 38): 62255-62266.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.11555Vancouver
Souza JG de, Morais KLP, Anglés-Cano E, Boufleur P, Mello ES de, Maria DA, Origassa CST, Zampolli H de C, Câmara NOS, Berra CM, Bosch RVB, Chudzinski-Tavassi AM. Promising pharmacological profile of a Kunitz-type inhibitor in murine renal cell carcinoma model [Internet]. OncoTarget. 2016 ; 7( 38): 62255-62266.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.11555